Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Lupin
Lupin launches Dasatinib tablets in United States
Lupin announced the launch of Dasatinib tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg, in the United States, following…
Lupin and TB Alliance collaborate to advance Telacebec for treatment of TB and other mycobacterial…
Lupin announced a strategic collaboration with TB Alliance, a nonprofit drug developer, to advance the clinical development and…
Lupin receives highest ESG rating from CDP for climate change and water security
Lupin announced that it has received the highest ‘A’ leadership rating from Climate Disclosure Project (CDP) for its exceptional…
Lupin and Galenicum sign license and supply agreement for Semaglutide in 23 Countries
Lupin announced a licensing and supply agreement through its subsidiary Lupin Atlantis Holdings SA (LAHSA) with Galenicum Health,…
Lupin receives positive CHMP opinion for biosimilar Ranibizumab
Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has…
Lupin’s biosimilar Armlupeg gains U.S.FDA approval
The product will be manufactured at Lupin’s biotech facility in Pune, which was inspected by the U.S. FDA prior to approval
US FDA conclude Lupin’s Nagpur Unit-1 facility inspection with zero observation
Lupin announced that the United States Food and Drug Administration (US FDA) has completed a product specific Pre-Approval…
Lupin receives EIR from U.S. FDA for Aurangabad facility
The Establishment Inspection Report follows a product-specific Pre-Approval Inspection conducted by the U.S. FDA at Lupin’s…
Lupin receives EIR from US FDA for its Pithampur unit-3 facility
Lupin announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration…